Table 1.

Patient characteristics of IgM gammopathy samples

ParameterIgM gammopathies (n = 29)WM (n = 23)IgM-MGUS (n = 6)P value
Age at diagnosis, y 61 (46-80) 61 (47-80) 65 (52-78) .51 
Male sex, n (%) 16 (55) 13 (57) 3 (50) .78 
Hemoglobin, g/dL 11.7 (8.1-16.2) 11.6 (8.1-15.8) 12.6 (11.1-16.2) .17 
Platelets, ×109/L 235 (77-512) 222 (77-512) 262 (207-338) .28 
β2-Microglobulin, μg/mL 3.1 (1.4-16.7) 3.1 (1.6-16.7) 2.8 (1.4-3.2) .52 
IgM, mg/dL 1770 (173-10 000) 3340 (173-10 000) 575 (283-1770) .01 
BM involvement, % 35 (0-95) 50 (10-95) 3.5 (0-10) <.001 
Abnormal FLC ratio, n (%) 7 (24) 5 (28) 2 (50) .39 
MYD88 mutated, n (%) 19 (83) 16 (84) 3 (75) .66 
CXCR4 mutated, n (%) 6 (26) 6 (32) .19 
Dx to LFU, mo 92 (3-201) 92 (3-194) 87 (26-201) .94 
ParameterIgM gammopathies (n = 29)WM (n = 23)IgM-MGUS (n = 6)P value
Age at diagnosis, y 61 (46-80) 61 (47-80) 65 (52-78) .51 
Male sex, n (%) 16 (55) 13 (57) 3 (50) .78 
Hemoglobin, g/dL 11.7 (8.1-16.2) 11.6 (8.1-15.8) 12.6 (11.1-16.2) .17 
Platelets, ×109/L 235 (77-512) 222 (77-512) 262 (207-338) .28 
β2-Microglobulin, μg/mL 3.1 (1.4-16.7) 3.1 (1.6-16.7) 2.8 (1.4-3.2) .52 
IgM, mg/dL 1770 (173-10 000) 3340 (173-10 000) 575 (283-1770) .01 
BM involvement, % 35 (0-95) 50 (10-95) 3.5 (0-10) <.001 
Abnormal FLC ratio, n (%) 7 (24) 5 (28) 2 (50) .39 
MYD88 mutated, n (%) 19 (83) 16 (84) 3 (75) .66 
CXCR4 mutated, n (%) 6 (26) 6 (32) .19 
Dx to LFU, mo 92 (3-201) 92 (3-194) 87 (26-201) .94 

All characteristics at the time of sample collection. IgM-gammopathies group contained all WM and IgM-MGUS samples. FLC data were available in 22 patients (18 WM, 4 IgM-MGUS). MYD88 and CXCR4 mutational data were available in 23 patients (19 WM, 4 IgM-MGUS). Unless specified, values represent median (range). Values in bold reach the signficance threshold of P < 0.05.

B2, β-2; BM, bone marrow; Dx, diagnosis; FLC, free light chain; IgM, immunoglobulin M; LFU, last follow-up.

or Create an Account

Close Modal
Close Modal